Global Antivenom Market Research Report 2018

January 2018 | 138 pages | ID: G5BFFF51A8CEN
QYResearch

Abstracts

This report studies the Antivenom market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Antivenom market by product type and applications/end industries.

The global Antivenom market is valued at 827.82 million USD in 2017 and is expected to reach 958.04 million USD by the end of 2023, growing at a CAGR of 2.46% between 2017 and 2023.

The major players in global Antivenom market include

• CSL Behring
• Merck & Co., Inc.
• BTG Plc
• Pfizer
• Haffkine Bio-Pharmaceutical Corporation
• Rare Disease Therapeutics
• Flynn Pharma
• Vins Bioproducts
• Bharat Serums and Vaccines
• Serum Biotech

Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of Antivenom in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

On the basis of product, the Antivenom market is primarily split into

• Polyvalent antivenom
• Monovalent antivenom

On the basis on the end users/applications, this report covers

• Retail Pharmacies
• Hospitals
• Others

Contents

1 ANTIVENOM MARKET OVERVIEW

1.1 Antivenom Product Overview
1.2 Antivenom Segment by Types (Product Category)
  1.2.1 Global Antivenom Sales and Growth (%) Comparison by Types (2013-2023)
  1.2.2 Global Antivenom Sales Market Share (%) by Types in 2017
  1.2.3 Polyvalent antivenom
  1.2.4 Monovalent antivenom
1.3 Global Antivenom Segment by Applications
  1.3.1 Global Antivenom Sales (K Vials) Comparison by Applications (2013-2023)
  1.3.2 Retail Pharmacies
  1.3.3 Hospitals
1.4 Global Antivenom Market by Regions (2013-2023)
  1.4.1 Global Antivenom Market Size and Growth (%) Comparison by Regions (2013-2023)
  1.4.2 North America Antivenom Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific Antivenom Status and Prospect (2013-2023)
  1.4.4 Europe Antivenom Status and Prospect (2013-2023)
  1.4.5 South America Antivenom Status and Prospect (2013-2023)
  1.4.6 Middle East and Africa Antivenom Status and Prospect (2013-2023)
1.5 Global Antivenom Market Size (2013-2023)
  1.5.1 Global Antivenom Revenue (Million USD) Status and Outlook (2013-2023)
  1.5.2 Global Antivenom Sales (K Vials) Status and Outlook (2013-2023)

2 GLOBAL ANTIVENOM MARKET COMPETITION BY MANUFACTURERS/BRAND

2.1 Global Antivenom Sales (K Vials) and Share by Manufacturers (2016-2017)
2.2 Global Antivenom Revenue (Million USD) and Share by Manufacturers (2016-2017)
2.3 Global Antivenom Average Price (USD/Vial) by Manufacturers (2016-2017)
2.4 Manufacturers Antivenom Manufacturing Base Distribution, Sales Area, Product Types
2.5 Antivenom Market Competitive Situation and Trends
  2.5.1 Antivenom Market Share (%) of Top 3 and Top 5 Manufacturers
  2.5.2 Mergers & Acquisitions, Expansion

3 GLOBAL ANTIVENOM SALES (K VIALS), REVENUE (MILLION USD) BY REGIONS (2013-2018)

3.1 Global Antivenom Sales (K Vials) and Market Share (%) by Regions (2013-2018)
3.2 Global Antivenom Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
3.3 Global Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
3.4 North America Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
3.5 Europe Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
3.6 Asia-Pacific Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
3.7 South America Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
3.8 Middle East and Africa Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)

4 GLOBAL ANTIVENOM SALES, REVENUE, PRICE TREND BY TYPES

4.1 Global Antivenom Sales (K Vials) and Market Share (%) by Types (2013-2018)
4.2 Global Antivenom Revenue and Market Share (%) by Types (2013-2018)
4.3 Global Antivenom Price (USD/Vial) by Type (2013-2018)
4.4 Global Antivenom Sales Growth by Type (2013-2018)

5 GLOBAL ANTIVENOM MARKET ANALYSIS BY APPLICATIONS

5.1 Global Antivenom Sales (K Vials) and Market Share (%) by Applications (2013-2018)
5.2 Global Antivenom Sales Growth Rate (%) by Applications (2013-2018)

6 GLOBAL ANTIVENOM MANUFACTURERS PROFILES/ANALYSIS

6.1 CSL Behring
  6.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.1.2 Antivenom Product Category, End Uses and Specification
  6.1.3 CSL Behring Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.2.2 Antivenom Product Category, End Uses and Specification
  6.2.3 Merck Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.2.4 Main Business/Business Overview
6.3 BTG Plc
  6.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.3.2 Antivenom Product Category, End Uses and Specification
  6.3.3 BTG Plc Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.4.2 Antivenom Product Category, End Uses and Specification
  6.4.3 Pfizer Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.4.4 Main Business/Business Overview
6.5 Haffkine Bio-Pharmaceutical Corporation
  6.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.5.2 Antivenom Product Category, End Uses and Specification
  6.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.5.4 Main Business/Business Overview
6.6 Rare Disease Therapeutics
  6.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.6.2 Antivenom Product Category, End Uses and Specification
  6.6.3 Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.6.4 Main Business/Business Overview
6.7 Flynn Pharma
  6.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.7.2 Antivenom Product Category, End Uses and Specification
  6.7.3 Flynn Pharma Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.7.4 Main Business/Business Overview
6.8 Vins Bioproducts
  6.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.8.2 Antivenom Product Category, End Uses and Specification
  6.8.3 Vins Bioproducts Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.8.4 Main Business/Business Overview
6.9 Bharat Serums and Vaccines
  6.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.9.2 Antivenom Product Category, End Uses and Specification
  6.9.3 Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.9.4 Main Business/Business Overview
6.10 Serum Biotech
  6.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  6.10.2 Antivenom Product Category, End Uses and Specification
  6.10.3 Serum Biotech Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
  6.10.4 Main Business/Business Overview

7 ANTIVENOM MANUFACTURING COST ANALYSIS

7.1 Antivenom Key Raw Materials Analysis
  7.1.1 Price Trend of Key Raw Materials
  7.1.2 Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
    7.2.2.1 USA Labor Cost Analysis
    7.2.2.2 European Union Costs Analysis
    7.2.2.3 China Labor Costs Analysis
    7.2.2.4 Japan Labor Costs Analysis
  7.2.3 Other Costs Analysis
    7.2.3.1 USA Cost of Electricity Analysis
    7.2.3.2 USA Water Cost Analysis
    7.2.3.3 Europe Cost of Electricity Analysis
    7.2.3.4 Europe Water Cost Analysis
    7.2.3.5 China Cost of Electricity Analysis
    7.2.3.6 China Water Cost Analysis
  7.2.4 Manufacturing Expenses

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antivenom Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antivenom Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 GLOBAL ANTIVENOM MARKET FORECAST (2018-2023)

11.1 Global Antivenom Sales (K Vials), Revenue (Million USD) Forecast (2018-2023)
  11.1.1 Global Antivenom Sales (K Vials) and Growth Rate (%) Forecast (2018-2023)
  11.1.2 Global Antivenom Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
  11.1.3 Global Antivenom Price and Trend Forecast (2018-2023)
11.2 Global Antivenom Sales (K Vials) and Revenue (Million USD) Forecast by Regions (2018-2023)
  11.2.1 North America Antivenom Sales (K Vials) and Revenue (Million USD) Forecast (2018-2023)
  11.2.2 Europe Antivenom Sales (K Vials) and Revenue (Million USD) Forecast (2018-2023)
  11.2.3 Asia-Pacific Antivenom Sales (K Vials) and Revenue (Million USD) Forecast (2018-2023)
  11.2.4 South America Antivenom Sales (K Vials) and Revenue (Million USD) Forecast (2018-2023)
  11.2.5 Middle East and Africa Antivenom Sales (K Vials) and Revenue (Million USD) Forecast (2018-2023)
11.3 Global Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) Forecast by Type (2018-2023)
11.4 Global Antivenom Sales (K Vials) Forecast by Application (2018-2023)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antivenom
Table Global Antivenom Sales (K Vials) and Growth Rate (%) Comparison by Types (Product Category) (2013-2023)
Figure Global Antivenom Sales Market Share (%) by Types in 2017
Figure Product Picture of Polyvalent antivenom
Figure Product Picture of Monovalent antivenom
Table Global Antivenom Sales (K Vials) Comparison by Applications (2013-2023)
Figure Global Antivenom Sales Market Share (%) by Applications in 2017
Figure Retail Pharmacies Examples
Figure Hospitals Examples
Figure Global Antivenom Market Size (Million USD) Comparison and Growth (%) by Regions (2013-2023)
Table Global Market Antivenom Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Antivenom Revenue (Million USD) and Growth Rate (%) (2013-2023)
Figure Asia-Pacific Antivenom Revenue (Million USD) and Growth Rate (%) (2013-2023)
Figure Europe Antivenom Revenue (Million USD) and Growth Rate (%) (2013-2023)
Figure South America Antivenom Revenue (Million USD) and Growth Rate (%) (2013-2023)
Figure Middle East and Africa Antivenom Revenue (Million USD) and Growth Rate (%) (2013-2023)
Figure Global Antivenom Revenue (Million USD) Status and Outlook (2013-2023)
Figure Global Antivenom Sales (K Vials) Status and Outlook (2013-2023)
Table Global Antivenom Sales (K Vials) of Key Manufacturers (2016-2017)
Table Global Antivenom Sales Share (%) by Manufacturers (2016-2017)
Figure 2016 Antivenom Sales Share (%) by Manufacturers
Figure 2017 Antivenom Sales Share (%) by Manufacturers
Table Global Antivenom Revenue (Million USD) by Manufacturers (2016-2017)
Table Global Antivenom Revenue Share (%) by Manufacturers (2016-2017)
Figure 2016 Global Antivenom Revenue Share (%) by Manufacturers
Figure 2017 Global Antivenom Revenue Share (%) by Manufacturers
Table Global Market Antivenom Average Price (USD/Vial) of Key Manufacturers (2016-2017)
Figure Global Market Antivenom Average Price (USD/Vial) of Key Manufacturers in 2017
Table Manufacturers Antivenom Manufacturing Base Distribution and Sales Area
Table Manufacturers Antivenom Product Category
Figure Antivenom Market Share (%) of Top 3 Manufacturers
Figure Antivenom Market Share (%) of Top 5 Manufacturers
Table: Mergers & Acquisitions, Expansion
Table Global Antivenom Sales (K Vials) by Regions (2013-2018)
Table Global Antivenom Sales Market Share (%) by Regions (2013-2018)
Figure Global Antivenom Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Antivenom Sales Market Share (%) by Regions
Table Global Antivenom Revenue (Million USD) by Regions (2013-2018)
Table Global Antivenom Revenue Market Share (%) by Regions (2013-2018)
Figure Global Antivenom Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Antivenom Revenue Market Share (%) by Regions
Table Global Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
Table North America Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
Table Europe Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
Table Asia-Pacific Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
Table South America Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
Table Middle East and Africa Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (%) (2013-2018)
Table Global Antivenom Sales (K Vials) by Types (2013-2018)
Table Global Antivenom Sales Share (%) by Types (2013-2018)
Figure Sales Market Share (%) of Antivenom by Types (2013-2018)
Figure 2017 Sales Market Share (%) of Antivenom by Types
Table Global Antivenom Revenue (Million USD) by Types (2013-2018)
Table Global Antivenom Revenue Share (%) by Types (2013-2018)
Figure Revenue Share (%) of Antivenom by Types (2013-2018)
Figure 2017 Revenue Market Share (%) of Antivenom by Types
Table Global Antivenom Price (USD/Vial) by Types (2013-2018)
Figure Global Antivenom Sales Growth (%) by Type (2013-2018)
Table Global Antivenom Sales (K Vials) by Applications (2013-2018)
Table Global Antivenom Sales Market Share (%) by Applications (2013-2018)
Figure Global Antivenom Sales Market Share (%) by Applications (2013-2018)
Figure Global Antivenom Sales Market Share (%) by Applications in 2017
Table Global Antivenom Sales Growth Rate (%) by Applications (2013-2018)
Figure Global Antivenom Sales Growth Rate (%) by Applications (2013-2018)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table CSL Behring Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure CSL Behring Antivenom Sales Growth Rate (%) (2016-2017)
Figure CSL Behring Antivenom Sales Market Share (%) (2016-2017)
Figure CSL Behring Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table Merck Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure Merck Antivenom Sales Growth Rate (%) (2016-2017)
Figure Merck Antivenom Sales Market Share (%) (2016-2017)
Figure Merck Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Table BTG Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table BTG Plc Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure BTG Plc Antivenom Sales Growth Rate (%) (2016-2017)
Figure BTG Plc Antivenom Sales Market Share (%) (2016-2017)
Figure BTG Plc Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table Pfizer Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure Pfizer Antivenom Sales Growth Rate (%) (2016-2017)
Figure Pfizer Antivenom Sales Market Share (%) (2016-2017)
Figure Pfizer Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Table Haffkine Bio-Pharmaceutical Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure Haffkine Bio-Pharmaceutical Corporation Antivenom Sales Growth Rate (%) (2016-2017)
Figure Haffkine Bio-Pharmaceutical Corporation Antivenom Sales Market Share (%) (2016-2017)
Figure Haffkine Bio-Pharmaceutical Corporation Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Table Rare Disease Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure Rare Disease Therapeutics Antivenom Sales Growth Rate (%) (2016-2017)
Figure Rare Disease Therapeutics Antivenom Sales Market Share (%) (2016-2017)
Figure Rare Disease Therapeutics Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Table Flynn Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table Flynn Pharma Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure Flynn Pharma Antivenom Sales Growth Rate (%) (2016-2017)
Figure Flynn Pharma Antivenom Sales Market Share (%) (2016-2017)
Figure Flynn Pharma Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Table Vins Bioproducts Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table Vins Bioproducts Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure Vins Bioproducts Antivenom Sales Growth Rate (%) (2016-2017)
Figure Vins Bioproducts Antivenom Sales Market Share (%) (2016-2017)
Figure Vins Bioproducts Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Table Bharat Serums and Vaccines Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure Bharat Serums and Vaccines Antivenom Sales Growth Rate (%) (2016-2017)
Figure Bharat Serums and Vaccines Antivenom Sales Market Share (%) (2016-2017)
Figure Bharat Serums and Vaccines Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Table Serum Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Introduction of Antivenom Product
Table Serum Biotech Antivenom Sales (K Vials), Revenue (Million USD), Price (USD/Vial), Gross Margin (%) and Market Share (%) (2016-2017)
Figure Serum Biotech Antivenom Sales Growth Rate (%) (2016-2017)
Figure Serum Biotech Antivenom Sales Market Share (%) (2016-2017)
Figure Serum Biotech Antivenom Revenue Market Share (%) (2016-2017)
Table Main Business Introduction
Figure Price Trend of Venom
Table Sales Base of Venom
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antivenom
Figure USA Labor Cost Analysis
Figure Cost of Employing a Factory Worker
Figure European Union Labor Costs
Figure China Labor Costs
Figure Japan Average Monthly Wages
Figure Japan Labor Force Participation Rate
Table Average Price of Electricity to Ultimate Customers 2007-2016
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Antivenom Industrial Chain Analysis
Table Raw Materials Sources of Antivenom Major Manufacturers in 2017
Table Major Buyers of Antivenom
Marketing Channels of Antivenom
Figure of Direct Marketing
Figure of Indirect Marketing
Figure Price Strategy Overview
Figure Brand Strategy Overview
Table Distributors/Traders List
Figure Porter’s Five Forces
Figure World Real GDP Growth Rate Map
Table Major Region Real GDP Growth Rate (%)
Figure Global Antivenom Sales (K Vials) and Growth Rate (%) Forecast (2018-2023)
Figure Global Antivenom Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Global Antivenom Price and Trend Forecast (2018-2023)
Table Global Antivenom Sales (K Vials) Forecast by Regions (2018-2023)
Figure Global Antivenom Sales Market Share (%) Forecast by Regions (2018-2023)
Figure North America Antivenom Sales (K Vials) and Growth Rate (%) Forecast (2018-2023)
Figure North America Antivenom Revenue and Growth Rate (%) Forecast (2018-2023)
Figure Europe Antivenom Sales (K Vials) and Growth Rate (%) Forecast (2018-2023)
Figure Europe Antivenom Revenue and Growth Rate (%) Forecast (2018-2023)
Figure Asia-Pacific Antivenom Sales (K Vials) and Growth Rate (%) Forecast (2018-2023)
Figure Asia-Pacific Antivenom Revenue and Growth Rate (%) Forecast (2018-2023)
Figure South America Antivenom Sales (K Vials) and Growth Rate (%) Forecast (2018-2023)
Figure South America Antivenom Revenue and Growth Rate (%) Forecast (2018-2023)
Figure Middle East and Africa Antivenom Sales (K Vials) and Growth Rate (%) Forecast (2018-2023)
Figure Middle East and Africa Antivenom Revenue and Growth Rate (%) Forecast (2018-2023)
Table Global Antivenom Sales (K Vials) Forecast by Type (2018-2023)
Figure Global Antivenom Sales Market Share (%) Forecast by Type (2018-2023)
Table Global Antivenom Revenue (Million USD) Forecast by Type (2018-2023)
Figure Global Antivenom Revenue Market Share (%) Forecast by Type (2018-2023)
Table Global Antivenom Price (USD/Vial) Forecast by Type (2018-2023)
Table Global Antivenom Sales (K Vials) Forecast by Application (2018-2023)
Figure Global Antivenom Sales Forecast by Application (2018-2023)